Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q2 2025 Earnings Call Transcript August 13, 2025
Allogene Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.23, expectations were $-0.28.
Operator: Hello, and thank you for standing by, and welcome to Allogene Therapeutics Second Quarter 2025 Conference Call. [Operator Instructions] Please be aware that today’s conference call is being recorded. I would now like to turn the call over to Christine Cassiano, Chief Corporate Affairs...
